. An unanswered question from the two studies 6, 7 is whether the mechanisms they describe are true for pexophagy activated by different signalling mechanisms or specific to certain cell types.
These contrasting reports that ubiquitylation on two different residues on PEX5 (Cys 11 versus K209) activates pexophagy also raise the question of whether these are unrelated or interdependent mechanisms. It is unclear, for example, whether the PEX5 K209R mutant is trapped on peroxisomes during the matrix protein import cycle, and if this is the underlying reason for triggering pexophagy. It is important to note that PEX5 is not a passive bystander to the effects of ROS. Cysteine residues located near the N-terminus of yeast and mammalian PEX5 proteins are mono-ubiquitylated and are also sensitive to redox conditions 11, 13 , which affect the oligomeric status of yeast Pex5 through disulfide bonding, as well as its affinity for cargo 13 . These studies, while whetting our appetites, raise questions that are ripe for further investigation. Is PEX5 the only ubiquitylation target driving pexophagy? There are hints that this might not be the case 6 . Does PEX5 fulfil this function primarily in response to ROS, or also to other stimuli, such as hypoxia 14 ( Fig. 2 ) and damaged or superfluous peroxisomes? Is pexophagy triggered only by peroxisome-generated ROS, or also by other cellular mechanisms that activate ROS (ref. 15)? PEX5 is a pivotal protein confronted with three possible fates during the matrix protein import cycle. Should it be recycled to allow another round of import of matrix proteins, or degraded by the UPS when its export from the peroxisome to the cytosol is inhibited 2 or perhaps destroyed through pexophagy along with the organelle it is associated with 6, 7 ? How is the choice between these fates determined mechanistically? Could pexophagy be the mammalian substitute for clearing jammed PTS receptors, instead of the UPS pathway found in yeast 2 but not yet in mammals? By identifying PEX5 as a mammalian target for ubiquitylation-induced pexophagy, the studies of Zhang et 
Endosomal integrin signals for survival
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The mechanisms underlying integrin-dependent signalling are a topic of continued study. Endocytosed integrins are now shown to drive assembly of signalling complexes on the cytoplasmic face of endocytic membranes to promote cancer cell survival and increase metastatic capacity following cell detachment.
Many epithelial and mesenchymal cells rely on integrin-mediated contact with the extracellular matrix (ECM) for growth and survival 1 . Therefore, when anchorage-dependent cells become detached from the ECM they cease to thrive and begin to die through a form of programmed cell death called anoikis 1 . When cells are attached to the matrix, integrins engage with the ECM and cluster at the plasma membrane to form large macromolecular signalling machines termed focal adhesions or focal contacts. Clustering of ligand-engaged integrins into focal adhesions promotes recruitment of signalling molecules such as focal adhesion kinase (FAK), and cytoskeletal adaptor proteins such as talin, to the integrin cytoplasmic domain (Fig. 1a) 2 . These adaptors, in turn, mediate mechanical links to the actin cytoskeleton to allow force transmission, but also bring in numerous signalling moieties that lead to activation of pathways that support cell growth and suppress anoikis 3, 4 . Prominent integrin-activated signalling pathways are the Ras-PI3K-PDK1-Akt and Ras-Raf-MEK-ERK axes and, although the mechanistic details of how integrin engagement leads to their activation remain somewhat obscure, there is copious evidence that following cell detachment the activity of these pathways is reduced, and this increases the likelihood of cells entering anoikis 3, 4 . In this issue of Nature Cell Biology Alanko et al. 5 report the existence of an integrin-dependent pathway that mediates anoikis resistance. They show that internalized integrins trigger the assembly of endosomal signalling complexes that include FAK, to foster cancer cell survival and to promote metastatic growth. Integrin endocytosis and recycling has been studied in some detail in the past few years and, in some cases, the way in which these processes influence signalling pathways to alter cell migration is well-described. For instance, the Rab11 effector, RCP coordinates recycling of integrins with receptor tyrosine kinases (RTKs), to promote Akt-mediated phosphorylation of RacGAP1 (refs 6-10) . Phosphorylated RacGAP1 then locally promotes RhoA activation at the tip of cellular protrusions, thus promoting invasiveness 7 .
Furthermore, tensin and Arf4-dependent internalization of ligand-engaged α 5 β 1 integrin to late endosomes is necessary for recruitment of mTOR to lysosomal membranes, providing a link between adhesion and nutrient signalling 10 . Despite these advances, very little is known about how integrins traffic following detachment of cells that are normally adherent. Alanko et al. 5 have shown that activated FAK colocalizes with internalized activated β 1 integrin and fibronectin on endosomes, rather than only at the ECM-cell attachment sites. They further showed that blocking endocytosis by depletion of Rab21 (a Rab subfamily GTPase that drives actively signalling integrins to endosomes) or dynamin inhibition reduced adhesion-dependent integrin signalling, as well as recruitment and activation of FAK to endosomal membranes. Using purified endosomes, the authors demonstrated that recombinant FAK can be recruited to, and activated at, these internal membranes in a β 1 integrin-dependent manner. Proteomic studies of different subcellular fractions revealed that endomembranes assemble protein complexes relating to integrin and FAK signalling that display both components distinct from and shared with integrin complexes found at the plasma membrane. Taken together these data elegantly show that following cell detachment integrins move from the cell surface to populate endosomes, and then remain in an active state within these compartments. This allows integrins to recruit FAK and other proteins, including focal adhesion components such as talin and vinculin, to endosomal membranes in order to facilitate downstream signalling, which can command anti-apoptotic signalling (Fig. 1b) . Although additional work is required to assess the precise nature and functions of these integrin-based endosomal complexes, the findings indicate that focal adhesion adaptors previously thought to be recruited only to adhesion sites at the plasma membrane, can physically interact with integrin cytodomains that are exposed on the cytoplasmic face of isolated endosomes, and that these complexes might also recruit distinct binding partners.
It is now well established that growth-factor receptors signal from endosomes in a way that influences anoikis. For instance, sorting nexin 1 (SNX1) has been shown to be downregulated during colon cancer progression, and this correlates with acquisition of anoikis resistance 11 . Mechanistically, downregulation of SNX1 drives endocytosis-dependent activation of EGFR and the MAPK pathway, leading to survival in absence of adhesion. More recently, Rab7 has been shown to promote EGFR-Akt signalling at late endosomes to sustain anchorage-independent growth in breast cancer cells 12 . However, none of these studies definitively link the loss of adhesion with anoikis resistance, nor do they explain how integrin signalling may be reprogrammed in response to cell detachment. Moreover, it has not been clear whether integrins can recruit adaptors to signal from endosomal membranes as has been shown to occur for RTKs. Alanko et al. 5 convincingly show that this can indeed occur, and by assessing anchorageindependent growth of cells in which integrin endocytosis and FAK signalling have been impaired, they demonstrate that this process mediates anti-apoptotic signalling to suppress anoikis. They further show that this occurs in a way that is pathophysiologically relevant, by linking this process to the acquisition of metastatic capacity by cancer cells. To metastasize, cancer cells must leave their organ of origin and travel through the lymphatic and circulatory system to colonize other organs. This entails loss of adhesive contact with the ECM and so, to complete this journey, cancer cells must develop mechanisms to circumnavigate anoikis. One way in which cancer cells suppress anoikis is through acquisition of activating mutations in anti-apoptotic pathways, such as the Ras-PI3K-PDK1-Akt axis, or by loss of tumour suppressors, such as PTEN (refs 3,4) . By demonstrating that Rab21 is required for breast cancer cells to colonize the lung, Alanko et al. show that there might be a route to anoikis suppression that does not necessitate mutation-based activation of prosurvival signalling pathways. Although further studies will be required to fully explore the in vivo roles of endosomal integrin signalling, these experiments provide encouraging evidence that this process dictates metastatic potential in vivo.
The present study provides intriguing insights into integrin signalling, but also poses a number of interesting questions for future research. A prominent open question is how this signalling can be maintained within an endosome where there is no apparent means for the generation of the forces that are generally accepted to be necessary for full integrin activation 13 . In addition, it will be important to determine what dictates the contribution of 'classic' focal adhesion signalling versus integrin endosomal signalling, and which integrin-containing signalling platforms are specifically assembled on endosomes. Lastly, it will be interesting to investigate this process in the context of mutations that are already known to suppress anoikis, such as those leading to constitutive activation of RTKs and their downstream signalling, in order to determine whether strategies aimed at targeting endosomal integrins could be combined with existing anti-oncogenic signalling therapies to kill circulating cancer cells. By providing a rationale for how cell detachment may help to suppress anoikis in cancer cells, this description of integrin signalling at endosomal membranes opens exciting avenues for future cell biological and cancer research studies. Internalized integrins then recruit active phosphorylated FAK to endosomal membranes to promote signalling to suppress anoikis.
